{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:49:24Z","timestamp":1761310164820,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.biopha.2004.04.008","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T05:21:14Z","timestamp":1082956874000},"page":"320-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients"],"prefix":"10.1016","volume":"58","author":[{"given":"Yvonne","family":"Richaud-Patin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Vega-Boada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vidaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2004.04.008_BIB1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2004.04.008_BIB2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2003-41135","article-title":"Therapy in myasthenia gravis and Lambert\u2013Eaton myasthenic syndrome","volume":"23","author":"Newsom-Davis","year":"2003","journal-title":"Semin Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2004.04.008_BIB3","first-page":"53","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biopha.2004.04.008_BIB4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/scbi.1997.0070","article-title":"Function, evolution and structure of multidrug resistance protein","volume":"8","author":"Deeley","year":"1997","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.biopha.2004.04.008_BIB5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0889-8588(18)30098-4","article-title":"Modulators of multidrug resistance. Preclinical studies","volume":"9","author":"Ford","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.biopha.2004.04.008_BIB6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0889-8588(18)30178-3","article-title":"Multidrug resistance. Clinical opportunities in diagnosis and circumvention","volume":"8","author":"Chan","year":"1994","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.biopha.2004.04.008_BIB7","first-page":"825","article-title":"Diagnostic test in myasthenia gravis. Gold standard conformation by a consensus","volume":"33","author":"Tellez-Zenteno","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.biopha.2004.04.008_BIB8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1172\/JCI2575","article-title":"HIV protease inhibitors and the MDR-1 multidrug transporter","volume":"101","author":"Lee","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopha.2004.04.008_BIB9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.biopha.2004.04.008_BIB10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0016-5085(00)70210-1","article-title":"High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy","volume":"118","author":"Farrell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2004.04.008_BIB11","first-page":"30","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I. Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome","volume":"67","author":"Llorente","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.biopha.2004.04.008_BIB12","first-page":"8","article-title":"Multidrug resistance genes in rheumatology: is their role immunological or pharmacological?","volume":"67","author":"Jorgensen","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.biopha.2004.04.008_BIB13","first-page":"40","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II. Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control","volume":"67","author":"D\u00edaz-Borj\u00f3n","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.biopha.2004.04.008_BIB14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2002.03709.x","article-title":"High P-glycoprotein mediated export observed in patients with a history of idiopathic thrombocytopenic purpura","volume":"118","author":"Levy","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2004.04.008_BIB15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0301-472X(03)00074-2","article-title":"Multidrug resistance-1 (MDR-1) in autoimmune disorders. III. Increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients","volume":"31","author":"Ruiz-Soto","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.biopha.2004.04.008_BIB16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/10428190290016791","article-title":"\u201cPros and cons\u201d on how to measure multidrug resistance in leukemias","volume":"43","author":"Kapplemayer","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.biopha.2004.04.008_BIB17","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/0959-8049(93)90215-2","article-title":"Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug resistance phenotype in Chinese hamster ovary cells","volume":"29A","author":"McClean","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.biopha.2004.04.008_BIB18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2003.08.002","article-title":"P-glycoprotein in autoimmune diseases","volume":"3","author":"Richaud-Patin","year":"2004","journal-title":"Autoimmunity Rev"},{"key":"10.1016\/j.biopha.2004.04.008_BIB19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V91.3.731","article-title":"Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings","volume":"91","author":"Distelhorst","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2004.04.008_BIB20","first-page":"806","article-title":"Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro","volume":"85","author":"Vilpo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2004.04.008_BIB21","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0021-9258(18)61633-3","article-title":"Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein","volume":"262","author":"Cornwell","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2004.04.008_BIB22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:32:11Z","timestamp":1760092331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332204000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0753332204000630"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2004.04.008","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2004.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}